ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

FEMY Femasys Inc

1.27
-0.05 (-3.79%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Femasys Inc FEMY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.05 -3.79% 1.27 17:33:37
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.33 1.27 1.33 1.27 1.32
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202407:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
28/3/202415:05GLOBEFemasys Announces Financial Results for Year Ended December..
21/3/202408:00GLOBEFemasys Invites Investors to View Fireside Chat Today, March..
20/3/202407:15GLOBEFemasys Announces Positive Topline Data from Pivotal Trial..
13/3/202408:00GLOBEFemasys to Participate in Fireside Chat to Discuss the..
06/3/202408:09EDGAR2Form 8-K - Current report
06/3/202408:00GLOBEFemasys Completes the First In-Office Commercial Procedure..
28/2/202408:16EDGAR2Form 8-K - Current report
13/2/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202420:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202407:47EDGAR2Form 8-K - Current report
02/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
08/12/202308:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202316:17EDGAR2Form S-3 - Registration statement under Securities Act of..
29/11/202315:05EDGAR2Form 8-K - Current report
22/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202316:30EDGAR2Form 8-K - Current report
15/11/202316:19EDGAR2Form 8-K - Current report
15/11/202307:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
01/11/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202307:01EDGAR2Form 8-K - Current report
03/10/202308:28EDGAR2Form 8-K - Current report
03/10/202308:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/9/202307:19EDGAR2Form 8-K - Current report
06/9/202316:00EDGAR2Form 8-K - Current report
10/8/202307:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:05EDGAR2Form 8-K - Current report
07/8/202307:40EDGAR2Form DEF 14A - Other definitive proxy statements
03/8/202308:04EDGAR2Form 8-K - Current report
28/7/202316:15EDGAR2Form PRE 14A - Other preliminary proxy statements
27/7/202308:04EDGAR2Form 8-K - Current report
14/7/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/7/202315:26EDGAR2Form S-1/A - General form for registration of securities..
03/7/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock